News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CellMed AG to Use Scarab Genomics’s Clean Genome E. coli in the Production of a New Medical Product


4/7/2011 9:21:48 AM

MADISON, Wis.--(BUSINESS WIRE)--Scarab Genomics announced a strategic agreement today with CellMed AG, a BTG International group company, in which CellMed AG will use Scarab Genomics’ Clean Genome E. coli Technology in a new product development in the life science field.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES